China Pharma Holdings, Inc. engages in the development, manufacture, and marketing of pharmaceutical products. The company is headquartered in Haikou, Hainan and currently employs 224 full-time employees. The company went IPO on 2000-02-15. The firm's products are for human use in connection, and with a variety of high-incidence and high-mortality diseases and medical conditions prevalent. The firm manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. In addition, the Company is also engaged in the production of comprehensive healthcare products and protective products.
CPHI stock price ended at $0.64 on 水曜日, after dropping 3.03%
On the latest trading day Feb 11, 2026, the stock price of CPHI fell by 3.03%, dropping from $0.67 to $0.64. During the session, the stock saw a volatility of 17.19%, with prices oscillating between a daily low of $0.64 and a high of $0.75. On the latest trading day, the trading volume for CPHI decreased by 911 shares, aligning with the declining prices, which may indicate weakening market confidence in the near term. In total, 25.1K shares were traded, with a market value of approximately $3.2M.